Ipsogen SA Company Profile

11:45 EST 11th December 2018 | BioPortfolio

News Articles [1 Associated News Articles listed on BioPortfolio]

QIAGEN launches QCI Interpret bioinformatics features for use for blood cancers as well as a novel myeloid gene panel for GeneReader NGS System

Highlighting Sample to Insight solutions for next-generation sequencing at American Society of Hematology 2018 meeting QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Ipsogen, Inc

Ipsogen foresees cancer, the second leading cause of death in developed countries, as a unique domain where drug development, commercialisation and prescription can benefit from biomarker discovery, v...

Ipsogen SA

More Information about "Ipsogen SA" on BioPortfolio

We have published hundreds of Ipsogen SA news stories on BioPortfolio along with dozens of Ipsogen SA Clinical Trials and PubMed Articles about Ipsogen SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ipsogen SA Companies in our database. You can also find out about relevant Ipsogen SA Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record